revenue ? What is your expected increase in this share during the coming years ?
We have been very steady in our growth in India and over the years have established ourselves to be a clear market leader across the Asia Pacific region . Over the years , India ’ s contribution has been very encouraging and in the coming years , we are not only looking to maintain momentum but also grow more in the country . India will always be an important market for us to fuel our operations and we look forward to serving more customers around the region and across the globe in the future .
What are your India plans for 2024 ? Looking ahead , what do you see as the key opportunities ?
India is an indispensable market to West and we maintain strong commitment with reputable position here . We aim to bring and inspire more innovation , grow team and talents , give back to the local communities as we grow together with the customers , the industry , and the country .
With emerging treatments coupled with a rapidly changing society , it is imperative to understand evolving patient needs and find solutions that cater to them . The pandemic was a learning experience where most thriving businesses had to pivot strategies and find innovative solutions . The GMP Annex 1 revisions was another hint that regulators around the world are demanding increasing levels of quality . Drug developers are more in need of a trusted partner that is capable to support the contamination control strategy and help them navigate the new regulations successfully .
“ The popularity of biosimilars will continue to rise , with more interest and investment , thereby opening more opportunities like funding .”
As a collective biomedical market , we are now moving out of siloed , traditional ways of working . Instead , there will arise more opportunities for collaboration and partnerships between different stakeholders to drive innovation and development . I believe we enjoy the opportunity to deliver more impactful solutions with our strong partnerships , like Daikyo and Corning , and in 2024 , we are in a good position to take on effective collaboration with valued partners from around the world .
BioTech
BIOVOICENEWS . COM 63